CASCADIAN THERAPEUTICS, INC. Financial Statements (2026 and earlier)
Company Profile
| Business Address |
3101 WESTERN AVE. SEATTLE, WA 98121 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 8731 - Commercial Physical and Biological Research (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | 12/31/2012 | |||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash, cash equivalents, and short-term investments | 62,805 | 56,360 | 57,671 | 60,027 | 81,254 | |||
| Cash and cash equivalent | 13,721 | 27,850 | 10,454 | 9,279 | 22,266 | |||
| Short-term investments | 49,084 | 28,510 | 47,217 | 50,748 | 58,988 | |||
| Receivables | 197 | 323 | ||||||
| Prepaid expense and other current assets | ✕ | ✕ | ✕ | ✕ | ✕ | 840 | ||
| Other undisclosed current assets | 1,649 | 1,618 | 1,186 | 720 | ||||
| Total current assets: | 64,454 | 57,978 | 58,857 | 60,944 | 82,417 | |||
| Noncurrent Assets | ||||||||
| Property, plant and equipment | 1,402 | 1,845 | 1,576 | 1,695 | 1,887 | |||
| Long-term investments and receivables | 6,043 | 12,535 | 2,502 | |||||
| Long-term investments | 6,043 | 12,535 | 2,502 | |||||
| Intangible assets, net (including goodwill) | 16,659 | 36,397 | 36,397 | 2,117 | 2,117 | |||
| Goodwill | 16,659 | 16,659 | 16,659 | 2,117 | 2,117 | |||
| Intangible assets, net (excluding goodwill) | 19,738 | 19,738 | ||||||
| Other noncurrent assets | 750 | 354 | 538 | 455 | ✕ | |||
| Prepaid expense and other noncurrent assets | ✕ | ✕ | ✕ | ✕ | ✕ | 512 | ||
| Deferred tax assets, net | 308 | 234 | 307 | |||||
| Other undisclosed noncurrent assets | (308) | (234) | (307) | |||||
| Total noncurrent assets: | 18,811 | 38,596 | 44,554 | 16,802 | 7,018 | |||
| TOTAL ASSETS: | 83,265 | 96,574 | 103,411 | 77,746 | 89,435 | |||
| LIABILITIES AND EQUITY | ||||||||
| Liabilities | ||||||||
| Current Liabilities | ||||||||
| Accounts payable and accrued liabilities | 8,421 | 4,650 | 4,432 | 4,466 | 3,027 | |||
| Employee-related liabilities | 4,274 | 1,522 | 1,614 | 1,311 | 1,042 | |||
| Accounts payable | 824 | 439 | 689 | 533 | 1,133 | |||
| Accrued liabilities | 3,323 | 2,689 | 2,129 | 2,622 | 852 | |||
| Deferred tax liabilities | 311 | 236 | 310 | |||||
| Other undisclosed current liabilities | 352 | 145 | (28) | (42) | (266) | |||
| Total current liabilities: | 8,773 | 4,795 | 4,715 | 4,660 | 3,071 | |||
| Noncurrent Liabilities | ||||||||
| Liabilities, other than long-term debt | 105 | 7,651 | 7,245 | 439 | 533 | |||
| Deferred revenue and credits | 337 | 439 | 533 | |||||
| Deferred tax liabilities, net | 6,908 | 6,908 | ||||||
| Other liabilities | 105 | 743 | ||||||
| Other undisclosed noncurrent liabilities | 1,097 | 3,508 | ||||||
| Total noncurrent liabilities: | 105 | 7,651 | 7,245 | 1,536 | 4,041 | |||
| Total liabilities: | 8,878 | 12,446 | 11,960 | 6,196 | 7,112 | |||
| Equity | ||||||||
| Equity, attributable to parent | 74,357 | 83,735 | 91,266 | 71,550 | 82,323 | |||
| Common stock | 353,849 | 353,856 | 353,856 | 353,854 | 353,853 | |||
| Additional paid in capital | 297,922 | 249,572 | 224,549 | 154,832 | 126,832 | |||
| Accumulated other comprehensive loss | (5,080) | (5,064) | (5,091) | (5,051) | (5,036) | |||
| Accumulated deficit | (572,334) | (514,629) | (482,048) | (432,085) | (393,326) | |||
| Total equity: | 74,357 | 83,735 | 91,266 | 71,550 | 82,323 | |||
| Other undisclosed liabilities and equity | 30 | 393 | 185 | |||||
| TOTAL LIABILITIES AND EQUITY: | 83,265 | 96,574 | 103,411 | 77,746 | 89,435 | |||
Income Statement (P&L) ($ in thousands)
| 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | 12/31/2012 | ||
|---|---|---|---|---|---|---|---|
| Revenues | 50 | 5 | 4,000 | ||||
| Revenue, net | 4,000 | ||||||
| Other income | 50 | 5 | ✕ | ✕ | ✕ | ||
| Gross profit: | 50 | 5 | 4,000 | ||||
| Operating expenses | (64,835) | (32,789) | (50,835) | (41,223) | (28,499) | ||
| Other undisclosed operating loss | (50) | (5) | (4,000) | ||||
| Operating loss: | (64,835) | (32,789) | (50,835) | (41,223) | (28,499) | ||
| Nonoperating income | 222 | 208 | 872 | 2,464 | 25,084 | ||
| Other nonoperating income (expense) | 222 | 80 | 76 | 137 | (127) | ||
| Interest and debt expense | (588) | ||||||
| Other undisclosed income from continuing operations before equity method investments, income taxes | 588 | ||||||
| Loss from continuing operations before income taxes: | (64,613) | (32,581) | (49,963) | (38,759) | (3,415) | ||
| Income tax benefit | 6,908 | ||||||
| Loss from continuing operations: | (57,705) | (32,581) | (49,963) | (38,759) | (3,415) | ||
| Loss before gain (loss) on sale of properties: | (57,705) | (32,581) | (49,963) | (38,759) | (3,415) | ||
| Net loss attributable to parent: | (57,705) | (32,581) | (49,963) | (38,759) | (3,415) | ||
| Other undisclosed net loss available to common stockholders, basic | (2,588) | ||||||
| Net loss available to common stockholders, basic: | (60,293) | (32,581) | (49,963) | (38,759) | (3,415) | ||
| Other undisclosed net loss available to common stockholders, diluted | (25,520) | ||||||
| Net loss available to common stockholders, diluted: | (60,293) | (32,581) | (49,963) | (38,759) | (28,935) | ||
Comprehensive Income ($ in thousands)
| 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | 12/31/2012 | ||
|---|---|---|---|---|---|---|---|
| Net loss: | (57,705) | (32,581) | (49,963) | (38,759) | (3,415) | ||
| Other comprehensive income (loss) | (16) | 27 | (40) | (15) | 8 | ||
| Comprehensive loss, net of tax, attributable to parent: | (57,721) | (32,554) | (50,003) | (38,774) | (3,407) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.